2006, Number 1
<< Back Next >>
Microbiología 2006; 48 (1)
Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne
Gübelin W, Martínez MA, Molina MT, Zapata S, Valenzuela ME
Language: English
References: 12
Page: 14-16
PDF size: 79.40 Kb.
ABSTRACT
In the last decade, a significant increase in the antimicrobial resistance of clinical specimens of Propionibacterium acnes to first line antibiotics used for acne treatment, has been informed in Europe and in the USA. No information about strains isolated from Latin-American countries is available. The antimicrobial susceptibility of 53 strains of P. acnes isolated from skin specimens of inflammatory acne patients, at the clinical Hospital University of Chile was tested. All isolates were susceptible to penicillin, minocycline, and nadifloxacin. Erythromycin and clindamycin resistance was found in 3.8 and 1.9% isolates respectively. Resistance to lymecycline was observed in one isolate, which was intermediate to tetracycline and doxycycline.
REFERENCES
Bojar, RA. & K.T. Holland. Acne and Propionibacterium acnes. Clin Dermatol 2004;22:375-9.
Brook, I. & E.H. Frazier. Infections caused by Propionibacterium species. Rev Infect Dis 1991;13:819-22.
Jakab, E., R. Zbinden, J. Gubler, C. Ruef, A. Von Graevenitz & M. Krause. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J Biol Med 1996;69:477-82.
Jappe, U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol 2003;83:241-8.
Gupta, M.A. & A.K. Gupta. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50.
Dreno, B., A. Reynaud, D. Moyse, H. Habert & H. Richet. Erythromycin-resistance of cutaneous bacterial flora in acne. Eur J Dermatol 2001;11:549-53.
Eady, E.A., M. Gloor & J.J. Leyden. Propionibacterium acnes resistance: a worldwide problem. Dermatology 2003;206:54-6.
Ross, J.I., A.M. Snelling, E. Carnegie, P.Coates, W.J. Cunliffe, V. Bettoli, G. Tosti, A. Akatsambas, J.I. Galvan Peréz del Pulgar, O. Rollman, L. Török, E.A. Eady & J.H. Cove. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78.
National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-Sixth Edition: Approved Standard M11-A6. NCCLS, Wayne, Pennsylvania, USA, 2004.
Akamatsu, H., H. Sasaki, I. Kurokawa, S. Nishijiima, Y. Asada & Y. Niwa. Effect of nadifloxacin on neutrophil functions. J Int Med Res 1995;23:19-26.
Grosshans, E., S. Belaich, J. Meynadier, M. Alirezai & L. Thomas. Comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris. Eur J Dermatol 1998; 8: 161-6.
Yamakawa, T., J. Mitsuyama & K. Hagashi. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother 2002; 49: 455-65.
Full text